Virpax Pharmaceuticals Inc's Comment on Supply Chain
The Drug Enforcement Administration (DEA) regulates controlled substances by classifying them into Schedules I through V based on their potential for abuse. Schedule II drugs are subject to stringent regulatory requirements governing their manufacturing, shipping, storage, sale, and use, including specific prescription rules and security measures. Facilities handling controlled substances must register annually with the DEA for each location and activity, with separate registrations required for importation and manufacturing. Security protocols include employee background checks and physical inventory controls. Entities must maintain records and submit reports to the DEA concerning the handling, distribution, theft, loss, and destruction of controlled substances. Import and export activities require special authorization and notification. The DEA also manages production through an annual quota system for Schedule II substances, allocating production and procurement quotas to companies and contract manufacturers, who must apply annually to produce or procure these substances.
Virpax Pharmaceuticals Inc's Comment on Supply Chain
The Drug Enforcement Administration (DEA) regulates controlled substances by classifying them into Schedules I through V based on their potential for abuse. Schedule II drugs are subject to stringent regulatory requirements governing their manufacturing, shipping, storage, sale, and use, including specific prescription rules and security measures. Facilities handling controlled substances must register annually with the DEA for each location and activity, with separate registrations required for importation and manufacturing. Security protocols include employee background checks and physical inventory controls. Entities must maintain records and submit reports to the DEA concerning the handling, distribution, theft, loss, and destruction of controlled substances. Import and export activities require special authorization and notification. The DEA also manages production through an annual quota system for Schedule II substances, allocating production and procurement quotas to companies and contract manufacturers, who must apply annually to produce or procure these substances.
Sources:
Virpax Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Virpax Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
